Anafilaksiye Akılcı Yaklaşım

ÖzAnafilaksi dakikalar içerisinde hızla ortaya çıkabilen ve ilerleyen, yaşamı tehditeden ciddi sistemik aşırı duyarlılık reaksiyondur. Semptomların erken tanınması, doğru tanı ve hızlı tedavi yaklaşımı çok önemlidir. Adrenalin anafilaksi tedavisinde tercih edilen ilk ilaçtır ve tanı konulduktan sonra hızla uygulanmalıdır. Anafilaksi tedavisinde kullanılan diğer ajanlar yardımcı ilaçlardır ve adrenalinin yerini asla tutamaz. Daha önce anafilaksi geçiren veya anafilaksi geçirme riski olan çocuk hastanın izleminde çocuğa, ailesine ve çocuğa bakım verenlere sorumlu alerjenden kaçınma, anafilaksi bulgularını tanıma ve gereğinde daha önceden verilen yazılı acil eylem planını uygulama ile ilgili bilgi ve eğitim verilmelidir. Bu vaka eşliğinde, süt ve süt ürünleri ile anafilaksi geçiren bir adolesana tedavi yaklaşımı tartışılmıştır.

Anahtar Kelimeler:

adrenalin, anafilaksi, besin alerjisi, epinefrin, otoenjektör

Logical Approach to Anaphylaxis

AbstractAnaphylaxis is a life-threatening severe systemic hypersensitivity reaction that can occur rapidly within minutes. Recognition of symptoms, definite diagnosis and rapid treatment approach are very important. Adrenaline is the first choice of medication in the anaphylaxis treatment and should be applied as soon as diagnosis is made. Secondary medications in the treatment of anaphylaxis are adjuvants and can never be replaced for adrenaline. Patients, families and caregivers of a child who has a history of anaphylaxis and/or risk of anaphylaxis should be informed about the avoidance of allergens, recognition ofthe anaphylaxis symptoms and, if necessary, the implementation of the planned treatment emergency plan. In this case, an adolescent patient with milk allergy was discussed.

Keywords:

adrenaline, anaphylaxis, foodallergy, epinephrine, auto-injector,

PDF

___

Kaynaklar 1.Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF Jr,Bock SA, Branum A, ve ark. Second symposium on the definitionand management of anaphylaxis: summary report—Second Na-tional Institute of Allergy and Infectious Disease/Food Allergy andAnaphylaxis Network Symposium. J Allergy Clin Immunol2006;117:391-7. 2.Loprinzi Brauer CE, Motosue MS, Li JT, Hagan JB, Bellolio MF,Lee S, ve ark. Prospective validation of the NIAID/FAAN criteriafor emergency department diagnosis of anaphylaxis. J Allergy ClinImmunol Pract 2016;4:1220-6. 3.Greenhawt M, Gupta R.S, Meadows J.A, Pistiner M, Spergel J.M,Camargo Jr C.A, ve ark Guiding Principles for the Recognition,Diagnosis, and Management of Infants with Anaphylaxis: An Ex-pert Panel Consensus. The Journal of Allergy and Clinical Immu-nology: In Practice 2019. 4.Grabenhenrich LB, Dolle S, Moneret-Vautrin A, Kohli A, Lange L, Spind-ler T, et al. Anaphylaxis in children and adolescents: The EuropeanAnaphylaxis Registry. J Allergy Clin Immunol 2016;137:1128-37. 5.Oropeza AR, Bindslev-Jensen C, Broesby-Olsen S, Kristensen T,Moller MB, Vestergaard H, et al. Patterns of anaphylaxis after di-agnostic workup: A follow-up study of 226 patients with suspec-ted anaphylaxis. Allergy 2017 May 19. doi: 10.1111/all.13207. 6.Järvinen KM, Sicherer SH, Sampson HA, Nowak-Wegrzyn A. Useof multiple doses of epinephrine in food-induced anaphylaxis in child-ren." Journal of Allergy and Clinical Immunology 2008; 133-138. 7.Vadas P, Boris P, ve Gary L. Platelet-activating factor, histami-ne, and tryptase levels in human anaphylaxis. Journal of Allergyand Clinical Immunology 2013; 144-149. 8.Schwartz LB, Yunginger JW, Miller J, Bokhari R, Dull D. Time cour-se of appearance and disappearance of human mast cell tryptase inthe circulation after anaphylaxis. J Clin Invest 1989;83:1551-55. 9.De Schryver S, Halbrich M, Clarke A, Vieille SL, Eisman H, Ali-zadehfar R ve ark. Tryptase levels in children presenting withanaphylaxis: Temporal trends and associated factors. J AllergyClin Immunol 2016;137:1138. 10.Orhan F, Cıvelek E, Şahiner Ü.M, Arga M, Can D, Çalıkaner A.Zve ark. "Anafilaksi: Türk Ulusal Rehberi 2018." Asthma AllergyImmunology/Astim Allerji Immunoloji 16 (2018). 11.Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphy-lactic reactions to food in children and adolescents. N Engl J Med1992;327:380-84. 12.Martelli A, Ghiglioni D, Sarratud T, Calcinai E, Veehof S, Terraccia-no L, et al. Anaphylaxis in the emergency department: a paediatric pers-pective. Curr Opin Allergy Clin Immunol 2008;8:321-29.13.Boyce JA, Assa’ad A, Burks AW, Jones SM, Sampson HA, WoodRA, et al. Guidelines for the diagnosis and management of foodallergy in the United States: summary of the NIAID sponsored Ex-pert Panel Report. J Allergy Clin Immunol 2010;126:1105-18. 14.Farkas H, Martinez-Saguer I, Bork K, Bowen T, Craig T, FrankM, et al. International consensus on the diagnosis and manage-ment of pediatric patients with hereditary angioedema with C1 in-hibitor deficiency. Allergy 2017;72:300-13. 15.Carter MC, Metcalfe DD, Komarow HD. Mastocytosis. ImmunolAllergy Clin North Am 2014;34:181-96. 16.Lieberman P, Nicklas RA, Oppenheimer J, Kemp SF, Lang DM,Bernstein DI, ve ark. The diagnosis and management of anaphy-laxis practice parameter: 2010 update. J Allergy Clin Immunol2010;126:477-80. 17.Muraro A, Roberts G, Worm M, Bilo MB, Brockow K, Fernández Ri-vas M ve ark. Anaphylaxis: guidelines from the European Academyof Allergy and Clinical Immunology. Allergy 2014;69:1026-45. 18.Pumphrey Richard SH. Fatal posture in anaphylactic shock. Jo-urnal of Allergy and Clinical Immunology 2003; 451-452. 19.Lockey RF, Kemp SF, Lieberman PL, Sheikh A. Anaphylaxis.In:Pawankar R, Canonica GW, Holgate S, Lockey R, Blaiss M, veark., editors. World Allergy Organization (WAO). White bookonallergy. Update 2013. Wisconsin: WAO; 48-53 20.Simons F ve Estelle R. First-aid treatment of anaphylaxis to food:focus on epinephrine. J Allergy Clin Immunol 2004;113:837-44.21.Sarinho, Emanuel, ve Maria das Graças Moura Lins. Severe formsof food allergy. Jornal de Pediatria 2017; 53-59. 22.Lee S, Sadosty AT, Campbell RL. Update on biphasic anaphyla-xis. Curr Opin Allergy Clin Immunol 2016;16:346-51. 23.Simons FE. Anaphylaxis: Assessment and Management. In: Le-ung DYM, Szefler SJ, Bonilla FA, Akdis C, Sampson HA (eds). Pe-diatric Allergy Principles and Practice. 3rd edition. Philadelphia:Saunders Elsevier, 2016:524-36. Rohacek M, Edenhofer H,Bircher A, Bingisser R. Biphasic anaphylactic reactions: occur-rence and mortality. Allergy 2014;69:791-97. 24.Manassis K. Managing anxiety related to anaphylaxis in child-hood: a systematic review. J Allergy (Cairo) 2012;2012:316296. 25.Akeson N, Worth A, Sheikh A. The psychosocial impact of anaphylaxison young people and their parents. Clin Exp Allergy 2007;37:1213-20.